Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
D L Kasper, … , H J Jennings, C J Baker
D L Kasper, … , H J Jennings, C J Baker
Published November 15, 1996
Citation Information: J Clin Invest. 1996;98(10):2308-2314. https://doi.org/10.1172/JCI119042.
View: Text | PDF
Research Article Article has an altmetric score of 9

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.

  • Text
  • PDF
Abstract

Group B Streptococcus (GBS) is an important perinatal pathogen. Because transplacentally acquired maternal antibodies to the GBS capsular polysaccharides (CPS) confer protection, prevention of infant disease may be possible after immunization of women. Unfortunately, the purified CPS of GBS are only variably immunogenic in adults; therefore to enhance immunogenicity we have designed and developed a CPS-protein conjugate vaccine. The lability of a conformationally dependent epitope on the III CPS containing a critical sialic acid residue was important to consider in vaccine design. 100 women were randomized to receive GBS type III CPS-tetanus toxoid conjugate (III-TT) vaccine at one of three doses; unconjugated GBS type III CPS; or saline. Serum samples were obtained before immunization and 2, 4, 8, and 26 wk thereafter, and specific antibody to type III CPS was measured. Vaccines were well tolerated. In sera from recipients of the highest dose of III-TT, CPS-specific IgG levels rose from a geometric mean of 0.09 microg/ml before immunization to 4.53 microg/ml 8 wk later, whereas levels in recipients of unconjugated type III CPS rose from 0.21 microg/ml to 1.41 microg/ml. Lower doses resulted in lower antibody levels. A > or = 4-fold rise in antibody concentration was achieved in 90% of recipients of III-TT compared with 50% of those that received III CPS (P = 0.0015). Antibodies evoked by the conjugate vaccine recognized a conformationally dependent epitope of the III-CPS, promoted opsonophagocytosis and killing of GBS, and, after maternal immunization, protected neonatal mice from lethal challenge with type III GBS. We conclude that directed coupling of type III GBS polysaccharide to a carrier protein yielded a conjugate vaccine with preserved expression of a highly labile conformational epitope involving sialic acid and enhanced immunogenicity compared with uncoupled CPS.

Authors

D L Kasper, L C Paoletti, M R Wessels, H K Guttormsen, V J Carey, H J Jennings, C J Baker

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1988 1967 Total
Citations: 1 1 3 5 4 2 5 5 4 9 8 3 6 6 8 4 4 10 3 5 12 9 12 7 12 7 12 15 6 1 1 190
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2001 (12)

Title and authors Publication Year
Potency of clinical group B streptococcal conjugate vaccines
LC Paoletti
Vaccine 2001
Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate
X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, G Wallerström, J Holmgren
Vaccine 2001
Impairment of Type III Group B Streptococcus-Stimulated Superoxide Production and Opsonophagocytosis by Neutrophils in Diabetes
MA Mazade, MS Edwards
Molecular Genetics and Metabolism 2001
Initial Studies of the Molecular Basis of Peptide Mimicry of Group B Streptococcal Type III Capsular Polysaccharide
SH Pincus, SR Lepage, RF Jung, JG Massey, M Jaseja
International Reviews of Immunology 2001
Anti-idiotypic Vaccination against Group B Streptococci
C Beninati, M Oggioni, G Mancuso, A Midiri, L Polonelli, G Pozzi, G Teti
International Reviews of Immunology 2001
Vaccines in Pregnancy
FM Munoz, JA Englund
Infectious Disease Clinics of North America 2001
Modulation of the complement system in the prevention and treatment of sepsis
E Andrews, PA Feldhoff, HA Lassiter
Seminars in Pediatric Infectious Diseases 2001
Maternal vaccines
WP Glezen
Primary Care Clinics in Office Practice 2001
The Molecular Immunology of Complex Carbohydrates —2
AM Wu
2001
Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines
EI Tuomanen, LC Paoletti, MA Rench, DL Kasper, D Molrine, D Ambrosino, CJ Baker
Infection and immunity 2001
Group B Streptococcus Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccines Prepared by Different Methods for Intranasal Immunization
EI Tuomanen, X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, J Holmgren
Infection and immunity 2001
Localization of Surface Immunogenic Protein on Group B Streptococcus
EI Tuomanen, S Rioux, D Martin, HW Ackermann, J Dumont, J Hamel, BR Brodeur
Infection and immunity 2001

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 15 patents
Referenced in 1 clinical guideline sources
65 readers on Mendeley
See more details